All In Biotech

Drug Trial Radar · NCT00001034

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

A Randomized, Comparative, Placebo-Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of Cytomegalovirus (CMV) Retinal and Gastrointestinal Mucosal Disease in HIV-Infected Individuals With Severe Immunosuppression

Last checked: Nov 20, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

850

Actual

Start

Not stated

Primary completion

Not stated

Study completion Aug 1995

Sponsor

Sponsor type
NIH
Collaborators
Hoffmann-La Roche
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Model
Parallel
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of oral ganciclovir for prophylaxis against cytomegalovirus (CMV) retinal and gastrointestinal mucosal disease in HIV-infected patients with severe immunosuppression. The most recent treatments against CMV disease have been ganciclovir and foscarnet. Until recently, both drugs required intravenous administration. An oral form of ganciclovir, if shown to be effective therapy against CMV, would be a more suitable method of administration for prophylaxis.

Conditions

  • Cytomegalovirus Retinitis
  • HIV Infections
  • Gastrointestinal Diseases

Interventions

  • GanciclovirDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Community Consortium of San Francisco

    San Francisco, California

  • Denver CPCRA / Denver Public Hlth

    Denver, Colorado

  • Wilmington Hosp / Med Ctr of Delaware

    Wilmington, Delaware

  • Veterans Administration Med Ctr / Regional AIDS Program

    Washington D.C., District of Columbia

  • AIDS Research Consortium of Atlanta

    Atlanta, Georgia

  • AIDS Research Alliance - Chicago

    Chicago, Illinois

  • Louisiana Comm AIDS Rsch Prog / Tulane Univ Med

    New Orleans, Louisiana

  • Comprehensive AIDS Alliance of Detroit

    Detroit, Michigan

  • Henry Ford Hosp

    Detroit, Michigan

  • Schering - Plough Corp

    Kenilworth, New Jersey

  • North Jersey Community Research Initiative

    Newark, New Jersey

  • Addiction Research and Treatment Corp

    Brooklyn, New York

  • Clinical Directors Network of Region II

    New York, New York

  • Harlem AIDS Treatment Group / Harlem Hosp Ctr

    New York, New York

  • Bronx Lebanon Hosp Ctr

    The Bronx, New York

  • Portland Veterans Adm Med Ctr / Rsch & Education Grp

    Portland, Oregon

  • Richmond AIDS Consortium

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.